ANGLE (LON:AGL) Stock Falls 11.3% – Here’s Why

ANGLE plc (LON:AGL)’s stock price dropped 11.3% during trading on Tuesday. The stock traded as low as GBX 2.33 and last traded at GBX 2.35. 1,682,496 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 1,623,727 shares. The stock had previously closed at GBX 2.65.

ANGLE Trading Down 11.3%

The business’s 50 day moving average price is GBX 2.35 and its 200-day moving average price is GBX 2.35. The company has a current ratio of 2.76, a quick ratio of 6.17 and a debt-to-equity ratio of 25.25. The company has a market cap of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.